Relapsing Multiple Sclerosis (RMS) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

Publisher Name :
Date: 01-Nov-2017
No. of pages: 40
Delivery of the Report will take 2-3 working days once order is placed.

DelveInsight's, Relapsing Multiple Sclerosis (RMS) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017" report provides comprehensive insights about marketed and Phase III products for the Relapsing Multiple Sclerosis (RMS). The report includes information of marketed products including their product description, patent details, forecasted sales till 2020 & API manufacturer details by country. It also provides a comprehensive understanding of the emerging Phase III therapies for Relapsing Multiple Sclerosis (RMS) which can turn out to be future prospective competitors for the marketed products. It will also put light on the current market trends.

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight team of industry experts.

Secondary information and data has been collected from various printable and non-printable sources like search engines, news websites, government websites, trade journals, white papers, magazines, trade associations, books, industry portals, industry associations and available databases.

Scope

  • A review of the marketed products for Relapsing Multiple Sclerosis (RMS) including their description, route of synthesis, regulatory milestones, forecasted sales estimates till 2020 and API manufacturer details.

  • Patent information coverage of the marketed products including the patent number, holder, grant and patent expiry details

  • API manufacturers for the marketed products with location details

  • Emerging Phase III product profiles for Relapsing Multiple Sclerosis (RMS) including product description, developmental activities, licensors & collaborators and chemical information

Reasons to Buy

  • API intelligence for marketed drugs for the indication and gaining insights of API manufacturers

  • Evaluate the marketing status and patent details of products to exploit opportunities for generic drug development

  • Design effective counter-strategies to gain competitive advantage by identifying the key patent expiry details and exclusivity with respect to the indication

  • Establish a comprehensive understanding of the emerging Phase III products which can be future competitors in this space

Relapsing Multiple Sclerosis (RMS) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

Table of Contents

DelveInsight Report Introduction
Overview
Comparative Analysis of Marketed and Emerging Products
Marketed Therapies

Drug Name: Company Name
- Product Description
- Regulatory Milestones
- Drug Historical Annual Global Sales
- Drug Forecasted Annual Global Sales
- Global Active Pharmaceutical Manufacturers for drug
- Patent Details

Emerging Therapies- Phase III

Drug Name: Company Name
- Product Description
- Research and Development
- Other Development Activities

Appendix
Methodology
Consulting Services
Disclaimer
About DelveInsight

List of Tables

Table 1: List of Marketed and Emerging Products
Table 2: Drug Annual Global Sales from 2011-2016 (in million USD)
Table 3: Drug Annual Global Sales from 2017-2020 (in million USD)
Table 4: Active Pharmaceutical Manufacturers by Country
Table 5: Active Pharmaceutical Manufacturers by Region

List of Figures

Figure 1: Comparative Analysis of Marketed and Emerging Products
Figure 2: Drug Annual Global Sales from 2011-2016 (in million USD)
Figure 3: Drug Annual Global Sales from 2017-2020 (in million USD)
Figure 4: Active Pharmaceutical Manufacturers by Country
Figure 5: Active Pharmaceutical Manufacturers by Region
  • Multiple Sclerosis - Pipeline Review, H2 2017
    Published: 21-Dec-2017        Price: US 2500 Onwards        Pages: 780
    Multiple Sclerosis - Pipeline Review, H2 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Multiple Sclerosis - Pipeline Review, H2 2017, provides an overview of the Multiple Sclerosis (Central Nervous System) pipeline landscape. Multiple sclerosis (MS) is a potentially debilitating disease in which body's immune system eats away at the protective sheath (myelin) that covers nerves. Damage to myelin causes ......
  • Multiple Sclerosis -Epidemiology Forecast to 2025
    Published: 01-Nov-2017        Price: US 2750 Onwards        Pages: 40
    DelveInsight "Multiple Sclerosis - Epidemiology Forecast To 2025" provides an overview of the epidemiology trends of Multiple Sclerosis in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology historical and forecasted data of Multiple Sclerosis prevalent or incident cases segmented by age, sex and subpopulations. The Report also discusses the prevailing risk factors, disease burden with special emphasis on the unmet medical need associated w......
  • Multiple Sclerosis - Market Insights, Epidemiology and Market Forecast - 2025
    Published: 01-Nov-2017        Price: US 5750 Onwards        Pages: 70
    DelveInsight's "Multiple Sclerosis - Market Insights, Epidemiology and Market Forecast - Market Insights, Epidemiology and Market Forecast - 2025" report provides an overview of the disease and in depth research related to Multiple Sclerosis - Market Insights, Epidemiology and Market Forecast for the 7MM (United States, Germany, France, Italy, Spain and UK) for the study period undertaken from 2015-2025. This report provides understanding of the patients affected, diagnosed patt......
  • Global Multiple Sclerosis Drugs Market Professional Survey Report 2017
    Published: 01-Nov-2017        Price: US 3500 Onwards        Pages: 105
    This report studies Multiple Sclerosis Drugs in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering - Biogen - Teva Pharmaceutical - Merck KGaA - Novartis ......
  • EpiCast Report: Multiple Sclerosis - Epidemiology Forecast to 2026
    Published: 01-Nov-2017        Price: US 3995 Onwards        Pages: 35
    EpiCast Report: Multiple Sclerosis - Epidemiology Forecast to 2026 Summary Multiple sclerosis (MS) is an autoimmune disease affecting principally the central nervous system that causes nerve sheath demyelination followed by axon damage and paralysis. MS symptoms include muscle weakness, weak reflexes, tremor, muscle spasm, prolonged double vision, slurred speech, and balance problems. It can occur at any age, but commonly affects people of ages 15-60 years. Women are ab......
  • Secondary Progressive Multiple Sclerosis (SPMS) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017
    Published: 01-Nov-2017        Price: US 2000 Onwards        Pages: 60
    DelveInsight's, Secondary Progressive Multiple Sclerosis (SPMS) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017" report provides comprehensive insights about marketed and Phase III products for the Secondary Progressive Multiple Sclerosis (SPMS). The report includes information of marketed products including their product description, patent details, forecasted sales till 2020 & API manufacturer details by country. It also provides a comprehensive understanding of the em......
  • Global Multiple Sclerosis Partnering 2010 to 2017
    Published: 01-Nov-2017        Price: US 1495 Onwards        Pages: 150
    "Delivery of this report will take 1-3 days after purchase." The Global Multiple Sclerosis Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies. • Trends in partnering deals • Top deals by value • Deals listed by company A-Z, industry sector, stage of development, technology type The report provides ......
  • Primary Progressive Multiple Sclerosis (PPMS) - Pipeline Insight, 2017
    Published: 01-Nov-2017        Price: US 1250 Onwards        Pages: 50
    DelveInsight's, "Primary Progressive Multiple Sclerosis (PPMS)-Pipeline Insights, 2017", report provides comprehensive insights of the ongoing therapeutic research and development across Primary Progressive Multiple Sclerosis (PPMS). The report provides a complete understanding of the pipeline activities covering all clinical, pre-clinical and discovery stage products. A comparative pipeline therapeutics assessment of Primary Progressive Multiple Sclerosis (PPMS) by development stage, therapy ty......
  • Relapsing Multiple Sclerosis (RMS) - Pipeline Insight, 2017
    Published: 01-Nov-2017        Price: US 1250 Onwards        Pages: 50
    DelveInsight's, "Relapsing Multiple Sclerosis (RMS)-Pipeline Insights, 2017", report provides comprehensive insights of the ongoing therapeutic research and development across Relapsing Multiple Sclerosis (RMS). The report provides a complete understanding of the pipeline activities covering all clinical, pre-clinical and discovery stage products. A comparative pipeline therapeutics assessment of Relapsing Multiple Sclerosis (RMS) by development stage, therapy type, route of administration and m......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs